145
Shang L﹟, Gu X﹟, Du S, Wang Y, Cao B*, Wang C*; CAP-China Network. The efficacy and safety of therapeutic lung lavage for exogenous lipoid pneumonia: a systematic review. Clin Respir J. 2020 Sep 17. doi: 10.1111/crj.13273. Epub ahead of print.
146
Wang Y﹟, Gu X, Xu J, Cao B*, Wang C. Remdesivir and COVID-19 - Authors' reply. Lancet. 2020 Oct 3;396(10256):954. doi: 10.1016/S0140-6736(20)32015-8.
147
Cao B﹟*, Hayden FG. Antiviral monotherapy for hospitalised patients with COVID-19 is not enough. Lancet. 2020 Oct 5;396(10259):1310–1. doi: 10.1016/S0140-6736(20)32078-X. Epub ahead of print.
148
Xu J﹟, Teng Y﹟, Shang L﹟, Gu X, Fan G, Chen Y, Tian R, Zhang S, Cao B*. The Effect of Prior ACEI/ARB Treatment on COVID-19 Susceptibility and Outcome: A Systematic Review and Meta-Analysis. Clin Infect Dis. 2020 Oct 20:ciaa1592. doi: 10.1093/cid/ciaa1592. Epub ahead of print.
149
Sun Y﹟, Li H﹟, Pei Z, Wang S, Feng J, Xu L, Gao P, Cao B,* Zhan S*. Incidence of community-acquired pneumonia in urban China: A national population-based study. Vaccine. 2020 Dec 14;38(52):8362-8370. doi: 10.1016/j.vaccine.2020.11.004. Epub 2020 Nov 13.
150
Zhang Y﹟, Li Y, Zeng J, Chang Y, Han S, Zhao J, Fan Y, Xiong Z, Zou X, Wang C, Li B, Li H, Han J, Liu X, Xia Y, Lu B*, Cao B*. Risk Factors for Mortality of Inpatients with Pseudomonas aeruginosa Bacteremia in China: Impact of Resistance Profile in the Mortality. Infect Drug Resist. 2020 Nov 12;13:4115-4123. doi: 10.2147/IDR.S268744.
151
Zhang Y﹟, Zhao J﹟, Zou X, Fan Y, Xiong Z, Li B, Wang C, Li H, Han J, Liu X, Xia Y, Lu B*, Cao B*; CAP-China network. Severity of influenza virus and respiratory syncytial virus coinfections in hospitalized adult patients. J Clin Virol. 2020 Dec;133:104685. doi: 10.1016/j.jcv.2020.104685.
152
Wang Y﹟, Zhong W﹟, Salam A﹟, Tarning J﹟, Zhan Q﹟, Huang JA﹟, Weng H, Bai C, Ren Y, Yamada K, Wang D, Guo Q, Fang Q, Tsutomu S, Zou X, Li H, Gillesen A, Castle L, Chen C, Li H, Zhen J, Lu B, Duan J, Guo L, Jiang J, Cao R, Fan G, Li J, Hayden FG, Wang C, Horby P, Cao B*. Phase 2a, open-label, dose-escalating, multi-center pharmacokinetic study of favipiravir (T-705) in combination with oseltamivir in patients with severe influenza. EBioMedicine. 2020 Nov 21;62:103125. doi: 10.1016/j.ebiom.2020.103125.
153
Shu H﹟, Li L, Wang Y, Guo Y, Wang C, Yang C, Gu L*, Cao B*. Prediction of the Risk of Hospital Deaths in Patients with Hospital-Acquired Pneumonia Caused by Multidrug-Resistant Acinetobacter baumannii Infection: A Multi-Center Study. Infect Drug Resist. 2020 Nov 19;13:4147-4154. doi: 10.2147/IDR.S265195.
154
Li H﹟, Ren L﹟, Zhang L﹟, Wang Y﹟, Guo L﹟, Wang C, Xiao Y, Wang Y, Rao J, Wang X, Liu Y, Huang C, Gu X, Fan G, Li H, Lu B, Cao B*, Wang J*. High Anal Swab Viral Load Predisposes Adverse Clinical Outcomes in Severe COVID-19 Patients. Emerg Microbes Infect. 2020 Dec 1:1-26. doi: 10.1080/22221751.2020.1858700. Epub ahead of print.
155
Chen S﹟, Prettner K﹟, Cao B, Geldsetzer P, Kuhn M, Bloom DE, Bärnighausen T, Wang C*. Revisiting the association between temperature and COVID-19 transmissibility across 117 countries. ERJ Open Res. 2020 Nov 2;6(4):00550-2020. doi: 10.1183/23120541.00550-2020.
156
Shang L﹟, Xu J, Cao B*. Viral pneumonia in China: from surveillance to response. Lancet Public Health. 2020 Dec;5(12):e633-e634. doi: 10.1016/S2468-2667(20)30264-4.
157
Yahav D﹟*, Yelin D﹟, Eckerle I, Eberhardt CS, Wang J, Cao B, Kaiser L. Definitions for COVID-19 reinfection, relapse and PCR re-positivity. Clin Microbiol Infect. 2020 Dec 4:S1198-743X(20)30724-2. doi: 10.1016/j.cmi.2020.11.028. Epub ahead of print.
158
Shuai Liu#, Hui Li, Yeming Wang, Haibo Li, Sisi Du, Xiaohui Zou, Xulong Zhang, Bin Cao*.High Expression of IL-36g in Influenza Patients Regulates Interferon Signaling Pathway and Causes Programmed Cell Death During Influenza Virus Infection. Frontiers in Immunology. 22 October 2020.doi: 10.3389/fimmu.2020.552606
159
Zhibo Liu#, Xia Li#, Guohui Fan#, Fei Zhou, Yeming Wang, Lixue Huang, Jiapei Yu, Luning Yang, Lianhan Shang, Ke Xie, Jiuyang Xu, Zhisheng Huang, Xiaoying Gu, Hui Li, Yi Zhang, Yimin Wang, Zhenghui Huang*, Bin Cao*. Low-to-moderate dose corticosteroids treatment in hospitalized adults with COVID-19 .Clin Microbiol Infect.2020 Sep 9;S1198-743X(20)30599-1.doi: 10.1016/j.cmi.2020.09.045.
160
Lili Ren L#, Guohui Fan#, Wenjuan Wu#, Li Guo#, Yeming Wang#, Xia Li#, Conghui Wang, Xiaoying Gu, Caihong, Ying Wang, Geng Wang, Fei Zhou, Zhibo Liu, Qing Ge, Yi Zhang, Hui Li, Lulu Zhang, Jiuyang Xu, Chen Wang, Jianwei Wang*, Bin Cao*. Antibody Responses and Clinical Outcomes in Adults Hospitalized with Severe COVID-19: A Post hoc Analysis of LOTUS China Trial. Clin Infect Dis. 2020 Aug 25;ciaa1247. doi: 10.1093/cid/ciaa1247.
